KUALA LUMPUR, Jan 7 (Bernama) -- Biocon Biologics is committed to implementing business expansion in Malaysia. Biocon Biologics is a global company with capabilities in the development, manufacturing ...

Biocon will distribute insulins and insulin delivery devices through Malaysia’s CCM Pharmaceuticals. Shares of Biocon were trading 2.79 per cent higher at Rs 1,026.30 apiece on BSE.

New Delhi, Jan 25 (PTI) Biotechnology major Biocon has bagged a MYR 300 million (about Rs 460.5 crore) contract from the Ministry of Health, Malaysia to supply recombinant human insulin formulations f ...

HSBC highlighted several factors that could drive earnings growth, including the FDA’s recent clearance of Biocon’s Malaysia plant, which addresses prior concerns regarding Good Manufacturing ...

Shares of Biocon soared over 4 percent on January 13 after the US Food and Drug Administration cleared arm Biocon Biologics' insulin facility in Malaysia, putting an end to a major regulatory ...